Hier finden Sie grundlegende Angaben zu klinischen Studien des Comprehensice Cancer Centers Mainfranken (CCC MF)
Filter aktiv
Seite 1 - Studien 1 bis 3 von insgesamt 3
- Rekrutierung läuftAn Open-label Multi-Cohort Phase 1b/2 Study to Evaluate the Safety, Efficacy, and Optimal Dose of ABBV-400 in Combination with Budigalimab in Advanced or Metastatic Non-Squamous NSCLC with No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations (AndroMETa-Lung-536)
- Rekrutierung läuftA Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB-11417 as Monotherapy, in Combination With Dexamethasone and Carfilzomib/ Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma and t(11; 14)Molekulare Marker
- Rekrutierung läuftNon-Hodgkin Lymphoma: Epcoritamab in Combination with Anti-Neoplastic AgentsMolekulare Marker